A detailed history of Nadler Financial Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Nadler Financial Group, Inc. holds 27,413 shares of PFE stock, worth $782,915. This represents 0.09% of its overall portfolio holdings.

Number of Shares
27,413
Previous 27,409 0.01%
Holding current value
$782,915
Previous $760,000 0.92%
% of portfolio
0.09%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$25.26 - $29.6 $101 - $118
4 Added 0.01%
27,413 $767,000
Q1 2024

Apr 26, 2024

BUY
$25.89 - $29.73 $5,229 - $6,005
202 Added 0.74%
27,409 $760,000
Q4 2023

Feb 02, 2024

SELL
$26.13 - $33.94 $44,734 - $58,105
-1,712 Reduced 5.92%
27,207 $783,000
Q3 2023

Oct 24, 2023

SELL
$32.09 - $37.51 $31,127 - $36,384
-970 Reduced 3.25%
28,919 $959,000
Q2 2023

Jul 31, 2023

SELL
$36.12 - $41.79 $3,684 - $4,262
-102 Reduced 0.34%
29,889 $1.1 Million
Q1 2023

Apr 19, 2023

SELL
$39.39 - $51.28 $38,365 - $49,946
-974 Reduced 3.15%
29,991 $1.22 Million
Q4 2022

Jan 30, 2023

BUY
$41.75 - $54.5 $876 - $1,144
21 Added 0.07%
30,965 $1.59 Million
Q3 2022

Oct 31, 2022

SELL
$43.76 - $53.42 $52,687 - $64,317
-1,204 Reduced 3.75%
30,944 $1.35 Million
Q2 2022

Jul 20, 2022

BUY
$46.53 - $55.17 $744 - $882
16 Added 0.05%
32,148 $1.69 Million
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $16,104 - $19,954
-352 Reduced 1.08%
32,132 $1.66 Million
Q4 2021

Jan 18, 2022

SELL
$41.32 - $61.25 $32,270 - $47,836
-781 Reduced 2.35%
32,484 $1.92 Million
Q3 2021

Oct 13, 2021

BUY
$39.25 - $50.42 $14,130 - $18,151
360 Added 1.09%
33,265 $1.43 Million
Q2 2021

Jul 16, 2021

SELL
$35.91 - $40.68 $41,727 - $47,270
-1,162 Reduced 3.41%
32,905 $1.29 Million
Q1 2021

Apr 14, 2021

SELL
$33.49 - $37.77 $1,473 - $1,661
-44 Reduced 0.13%
34,067 $1.23 Million
Q4 2020

Jan 26, 2021

BUY
$33.47 - $42.56 $84,344 - $107,251
2,520 Added 7.98%
34,111 $1.26 Million
Q3 2020

Oct 07, 2020

BUY
$31.75 - $37.25 $128,047 - $150,229
4,033 Added 14.63%
31,591 $1.16 Million
Q2 2020

Jul 09, 2020

SELL
$30.12 - $36.54 $14,909 - $18,087
-495 Reduced 1.76%
27,558 $901,000
Q1 2020

Apr 09, 2020

SELL
$27.03 - $38.62 $42,491 - $60,710
-1,572 Reduced 5.31%
28,053 $916,000
Q4 2019

Jan 08, 2020

SELL
$32.92 - $37.36 $8,657 - $9,825
-263 Reduced 0.88%
29,625 $1.16 Million
Q3 2019

Oct 03, 2019

SELL
$32.49 - $42.13 $39,897 - $51,735
-1,228 Reduced 3.95%
29,888 $1.07 Million
Q2 2019

Jul 16, 2019

SELL
$36.98 - $41.52 $5,288 - $5,937
-143 Reduced 0.46%
31,116 $1.35 Million
Q1 2019

Apr 04, 2019

SELL
$37.5 - $41.2 $28,162 - $30,941
-751 Reduced 2.35%
31,259 $1.33 Million
Q4 2018

Jan 17, 2019

SELL
$38.47 - $43.86 $13,733 - $15,658
-357 Reduced 1.1%
32,010 $1.4 Million
Q3 2018

Oct 09, 2018

BUY
$34.47 - $41.81 $1,654 - $2,006
48 Added 0.15%
32,367 $1.43 Million
Q2 2018

Jul 10, 2018

BUY
$32.98 - $35.16 $86,671 - $92,400
2,628 Added 8.85%
32,319 $1.17 Million
Q1 2018

Apr 05, 2018

SELL
$31.91 - $37.02 $102,112 - $118,464
-3,200 Reduced 9.73%
29,691 $1.05 Million
Q4 2017

Jan 12, 2018

SELL
$33.26 - $35.29 $9,479 - $10,057
-285 Reduced 0.86%
32,891 $1.19 Million
Q3 2017

Oct 11, 2017

BUY
$31.0 - $34.15 $1.03 Million - $1.13 Million
33,176
33,176 $1.18 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nadler Financial Group, Inc. Portfolio

Follow Nadler Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nadler Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nadler Financial Group, Inc. with notifications on news.